Hepatocellular carcinoma: Diagnostics and screening

Journal of Evaluation in Clinical Practice

Volumn 18, Issue 2, 2012, Pages 335-342

  Patel, Madhvi ^a   Shariff, Mohamed I F ^a   Ladep, Nimzing G ^a   Thillainayagam, Andrew V ^a   Thomas, Howard C ^a   Khan, Shahid A ^a   Taylor Robinson, Simon D ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

fetoprotein; genomics; hepatocellular carcinoma; metabonomics; proteomics

Indexed keywords

AFLATOXIN; ALPHA FETOPROTEIN; ALPHA LEVO FUCOSIDASE; DECARBOXYPROTHROMBIN; FLUORODEOXYGLUCOSE F 18; GLYPICAN 3;

ALCOHOLISM; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC PROCEDURE; ECHOGRAPHY; GENETIC DISORDER; GENOMICS; HEPATITIS B; HEPATITIS C; HUMAN; LENTIL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METABOLIC DISORDER; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEOMICS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROLOGY;

CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; GENOMICS; HUMANS; INCIDENCE; LIVER NEOPLASMS; MASS SCREENING; METABOLOMICS; POPULATION SURVEILLANCE; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858132297     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2010.01599.x     Document Type: Article

References (65)

1. Bruix, J., &, Sherman, M., (2005) Management of hepatocellular carcinoma. Hepatology, 42 (5), 1208.
2. Saar, B., &, Kellner-Weldon, F., (2008) Radiological diagnosis of hepatocellular carcinoma. Liver International, 28 (2), 189.
3. Stefaniuk, P., Cianciara, J., &, Wiercinska-Drapalo, A., (2010) Present and future possibilities for early diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology, 16 (4), 418.
4. Hepatocellular carcinoma-United States, 2001-2006. MMWR Morbidity and Mortality Weekly Report, 2010; 59 (17), 517-520.
5. Colombo, M., de Franchis, R., &, del Ninno, E., (1991) Hepatocellular carcinoma in Italian patients with cirrhosis. New England Journal of Medicine, 325 (10), 675-680.
6. Jelic, S., (2009) Hepatocellular carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology, 20 (SUPPL. 4), 41-45.
7. Sherman, M., (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Seminars in Liver Disease, 30 (01), 003-016.
8. Shariff, M. I. F., Cox, I. J., Gomaa, A. I., Khan, S. A., Gedroyc, W., &, Taylor-Robinson, S., (2009) Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology, 3 (4), 353-367.
9. Yu, M. W., &, Chen, C. J., (1993) Elevated serum testosterone levels and risk of hepatocellular carcinoma. Cancer Research, 53 (4), 790-794.
10. Naugler, W., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A., &, Karin, M., (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science, 317 (5834), 121-124.
11. Beasley, R. P., Lin, C., Hwang, L., &, Chien, C., (1981) Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22 707 men in Taiwan. The Lancet, 318 (8256), 1129-1133.
12. Sun, C., Wu, D., Lin, C., Lu, S., You, S., Wang, L., Wu, M., &, Chen, C., (2003) Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. American Journal of Epidemiology, 157 (8), 674-682.
13. Montalto, G., Cervello, M., Giannitrapani, L., Dantona, F., Terranova, A., &, Castagnetta, L. A. M., (2002) Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Annals of the New York Academy of Sciences, 963, 13-20.
14. Bosch, F. X., Ribes, J., Daz, M., &, Clries, R., (2004) Primary liver cancer: worldwide incidence and trends. Gastroenterology, 127 (5 SUPPL. 1), S5-S16.
15. Khan, S., Taylor-Robinson, S., Toledano, M., Beck, A., Elliott, P., &, Thomas, H., (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. Journal of Hepatology, 37 (6), 806-813.
16. Fargion, S., Fracanzani, A. L., Piperno, A., Braga, M., D'Alba, R., Ronchi, G., &, Fiorelli, G., (1994) Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology, 20 (6), 1426-1431.
17. Caballera, L., Pars, A., Castells, A., Gins, A., Bru, C., &, Rods, J., (2001) Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. The American Journal of Gastroenterology, 96 (4), 1160-1163.
18. El-Serag, H., &, Rudolph, K. L., (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132 (7), 2557-2576.
19. El-Serag, H., Tran, T., &, Everhart, J., (2004) Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology, 126 (2), 460-468.
20. Allen, N., Beral, V., Casabonne, D., Kan, S., Reeves, G., Brown, A., &, Green, J., (2009) Moderate alcohol intake and cancer incidence in women. Journal of the National Cancer Institute, 101 (5), 296-305.
21. Donato, F., Tagger, A., Gelatti, U., et al,. (2002) Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. American Journal of Epidemiology, 155 (4), 323-331.
22. Hart, C., Morrison, D., Batty, G. D., Mitchell, R., &, Smith, G., (2010) Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies. British Medical Journal British Medical Journal (Clinical Research Ed.), 340, c1240-c1240.
23. Larsson, S. C., &, Wolk, A., (2007) Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. The British Journal of Cancer, 97 (7), 1005-1008.
24. Groopman, J. D., Scholl, P., &, Wang, J. S., (1996) Epidemiology of human aflatoxin exposures and their relationship to liver cancer. Progress in Clinical and Biological Research, 395, 211-222.
25. Qian, G. S., Ross, R. K., Yu, M. C., Yuan, J. M., Gao, Y. T., Henderson, B. E., Wogan, G., &, Groopman, J., (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiology, Biomarkers & Prevention, 3 (1), 3-10.
26. Zhang, B., Yang, B., &, Tang, Z., (2004) Randomized controlled trial of screening for hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology, 130 (7), 417.
27. Mazzaferro, V., Llovet, J., Miceli, R., et al,. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. The Lancet Oncology, 10 (1), 35.
28. Zhang, B., &, Yang, B., (1999) Combined alpha fetoprotein testing and ultrasonography as a screening test for primary liver cancer. Journal of Medical Screening, 6 (2), 108-110.
29. Ryder, S. D., (2003) Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut, 52 (3), 1-8.
30. Ariff, B., Lloyd, C., Khan, S., Shariff, M., Thillainayagam, A., Bansi, D., Khan, S., Taylor-Robinson, S., &, Lim, A., (2009) Imaging of liver cancer. World Journal of Gastroenterology, 15 (11), 1289-1300.
31. Pompili, M., Riccardi, L., Semeraro, S., Orefice, R., Elia, F., Barbaro, B., Covino, M., Grieco, A., Gasbarrini, G., &, Raspaccini, G., (2008) Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver. Digestive and Liver Disease, 40 (3), 206-215.
32. Murakami, T., Kim, T., Takahashi, S., &, Nakamura, H., (2002) Hepatocellular carcinoma: multidetector row helical CT. Abdominal Imaging, 27, 139-146.
33. Nakimoto, T., Yamashita, Y., Sumi, S., Tang, Y., &, Takahashi, M., (1997) Focal liver masses: characterization with diffusion-weighted echo-planar MR imaging. Radiology, 204, 739-744.
34. Teefey, S., Hildeboldt, C., Dehdashti, F., et al,. (2003) Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology, 226 (2), 533-542.
35. Snowberger, N., Chinnakotla, S., Lepe, R. M., Peattie, J., Goldstein, R., Klintmalm, G. B., &, Davis, G., (2007) Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Alimentary Pharmacology & Therapeutics, 26 (9), 1187-1194.
36. Lauenstein, T., Salman, K., Morreira, R., Heffron, T., Spivey, J., Martinez, E., Sharma, P., &, Martin, D., (2007) Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. AJR. American Journal of Roentgenology, 189 (3), 663-670.
37. Khan, M. A., Combs, C. S., Brunt, E. M., Lowe, V. J., Wolverson, M. K., Solomon, H., Collins, B., &, Di Bisceglie, A., (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. Journal of Hepatology, 32 (5), 792-797.
38. Ho, C., Yu, S. C. H., &, Yeung, D. W. C., (2003) 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. The Journal of Nuclear Medicine, 44 (2), 213-221.
39. Grizzi, F., Franceschini, B., Hamrick, C., Frezza, E., Cobos, E., &, Chiriva-Internati, M., (2007) Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma. Journal of Translational Medicine, 5, 3.
40. Marrero, J., Su, G., Wei, W., Emick, D., Conjeevaram, H., Fontana, R., &, Lok, A., (2003) Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology, 37 (5), 1114-1121.
41. Nakamura, S., Nouso, K., Sakaguchi, K., et al,. (2006) Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. The American Journal of Gastroenterology, 101 (9), 2038.
42. Koike, Y., Shiratori, Y., Sato, S., Obi, S., Teratani, T., Imamura, M., Yoshida, H., Shiina, S., &, Omata, M., (2001) Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer, 91 (3), 561-569.
43. Khien, V. V., Mao, H. V., Chinh, T. T., et al,. (2001) Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. The International Journal of Biological Markers, 16 (2), 105-111.
44. Kumada, T., Nakano, S., Takeda, I., Kiriyama, S., Sone, Y., Hayashi, K., Katoh, H., Endo, T., Sassa, T., &, Satomura, S., (1999) Clinical utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. Journal of Hepatology, 30 (1), 125-130.
45. Tangkijvanich, P., Tosukhowong, P., Bunyongyod, P., Lertmaharit, S., Hanvivatvong, O., Kullavanijaya, P., &, Poovorawan, Y., (1999) Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand. Southeast Asian Journal of Tropical Medicine and Public Health, 30 (1), 110-114.
46. Gomaa, A., Khan, S., Leen, E. L. S., Waked, I., &, Taylor-Robinson, S., (2009) Diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology, 15 (11), 1301-1314.
47. Nakatsura, T., Yoshitake, Y., Senju, S., et al,. (2003) Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochemical and Biophysical Research Communications, 306 (1), 16-25.
48. Capurro, M., Wanless, I., Sherman, M., Deboer, G., Shi, W., Miyoshi, E., &, Filmus, J., (2003) Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology, 125 (1), 89-97.
49. Nicholson, J., &, Lindon, J., (2008) Systems biology: Metabonomics. Nature, 455 (7216), 1054.
50. Soper, R., Himmelreich, U., Painter, D., Somorjai, R., Lean, C., Dolenko, B., Mountford, C., &, Russell, P., (2002) Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy. Pathology, 34 (5), 417.
51. Yang, Y., Li, C., Nie, X., Feng, X., Chen, W., Yue, Y., Tang, H., &, Deng, F., (2007) Metabonomic studies of human hepatocellular carcinoma using high-resolution magic-angle spinning 1H NMR spectroscopy in conjunction with multivariate data analysis. Journal of Proteome Research, 6 (7), 2605.
52. Warburg, O., (1958) The effect of hydrogen peroxide on cancer cells and on embryonic cells. Acta-Unio Internationalis Contra Cancrum, 14 (1), 55-57.
53. Gao, H., Lu, Q., Liu, X., Cong, H., Zhao, L., Wang, H., &, Lin, D., (2009) Application of 1H NMR-based metabonomics in the study of metabolic profiling of human hepatocellular carcinoma and liver cirrhosis. Cancer Science, 100 (4), 782.
54. Wu, H., Xue, R., Dong, L., Liu, T., Deng, C., Zeng, H., &, Shen, X., (2009) Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Analytica Chimica Acta, 648 (1), 98.
55. Shariff, M. I. F., Ladep, N., Cox, I. J., et al,. (2010) Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population. Journal of Proteome Research, 9 (2), 1096-1103.
56. Chignard, N., &, Beretta, L., (2004) Proteomics for hepatocellular carcinoma marker discovery. Gastroenterology, 127 (5 SUPPL. 1), S120-S125.
57. Paradis, V., Degos, F., Dargre, D., et al,. (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology, 41 (1), 40-47.
58. Geng, X., Wang, F., Li, Y. G., Zhu, G. P., &, Zhang, W. M., (2007) SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research, 26 (4), 505-508.
59. Zinkin, N., Grall, F., Bhaskar, K., et al,. (2008) Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clinical Cancer Research, 14 (2), 470-477.
60. Lau, W. Y., Lai, P. B., &, Leung, M. F., (2000) Differential expression of hepatocellular carcinoma using cDNA microarray analysis. Oncology Research, 12 (2), 59-69.
61. Midorikawa, Y., Ishikawa, S., Iwanari, H., Imamura, T., Sakamoto, H., Miyazono, K., Kodama, T., Makuuchi, M., &, Aburatani, H., (2003) Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. International Journal of Cancer, 103 (4), 455-465.
62. Iizuka, N., Oka, M., Yamada-Okabe, H., et al,. (2003) Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. The Lancet, 361 (9361), 923-929.
63. Kim, J., Ye, Q., Forgues, M., Chen, Y., Budhu, A., Sime, J., Hofseth, L., Kaul, R., &, Wang, X., (2004) Cancer-associated molecular signature in the tissue samples of patients with cirrhosis. Hepatology, 39 (2), 518-527.
64. Nam, S., Lee, J., Noh, J., et al,. (2006) Comparative analysis of expression profiling of early-stage carcinogenesis using nodule-in-nodule-type hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology, 18 (3), 239-247.
65. Harvey, C. J., &, Albrecht, T., (2001) Ultrasound of focal liver lesions. European Radiology, 11 (9), 1578-1593.